IRCT20220817055730N1已完成2 期
Investigating the effect of metformin on disease activity in systemic lupus erythematosus
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 years 至 no limit（—）
- 性别
- All
入选标准
- •suffering from Systemic lupus erythematosus disease
- •Age above 18 years
排除标准
- •Kidneys involvement
- •Central Nervous System involvement
- •Heart failure
- •Hepatic failure
- •Breast feeding
- •Alcohol consumption
- •Metformin use due to Diabetes mellitus
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88
招募中
2 期
The effect of Metformin on complication of strokesStroke.Stroke, not specified as haemorrhage or infarctionIRCT20160318027097N5Vice Chancellor for research of Ardebil University of Medical Sciences100
已完成
不适用
Effect of Metformin (Drug)in Patients With Cryptogenic Cirrhosis (Liver Disease) With DiabetesCTRI/2018/03/012814Institute of liver and Biliary Sciences86
Unknown
不适用
Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)Liver DiseasesNCT00247117Kaplan Medical Center15
尚未招募
4 期
Investigating the effects of metformin on growth factors involved in prostate cancer progression in prostate cancer patientsProstate cancerACTRN12615000778583Western Sydney Local Health District26